videos Archives

Robots Learned to Feel. Markets Are Paying Attention -( $AMD )

by John F. Heerdink, Jr. July 27, 2026 157Views 0Likes

At an AMD conference, a humanoid robot named Gene.01 did something that would have felt like science fiction a decade ago: it sensed a human hand before contact, registered touch with unusual precision, and reacted with a kind of mechanical politeness that…

As Samsung and SK Hynix Rise, Seoul Housing Feels the Afterglow -( $SKHY )

by John F. Heerdink, Jr. July 27, 2026 219Views 0Likes

South Korea’s AI trade is no longer just a chip story; it is becoming a property story too, with Samsung Electronics and SK Hynix (SKHY) helping drive a market rally that is now spilling into apartments, down payments, and the psychology of…

Jamie Dimon on Bonds, AI and Deficits: Why Wall Street Should Stay Alert -( $JPM $SPY)

by John F. Heerdink, Jr. July 23, 2026 262Views 0Likes

Jamie Dimon’s latest interview had the kind of calm, polished menace Wall Street loves: the economy is sturdy, AI is real, bonds are not his favorite date, and government deficits are the sort of thing that tend to arrive uninvited and stay…

The $600 Million Cut: Ben Affleck’s AI Company, Netflix’s Bet, and the Data Behind the Drama – ( $NFLX $NVDA $SMWB )

by John F. Heerdink, Jr. July 21, 2026 376Views 0Likes

Hollywood just added a new kind of tentpole: the AI post‑production startup. Investors would be wise to pay attention, because behind the celebrity headlines around Ben Affleck’s InterPositive sale to Netflix sits an emerging stack that runs straight through NVIDIA (NVDA) and…

Unbeatable Spain, Unbathable Baby: How Lamine Yamal Turned A Messi Bathtub Cameo Into Football Alpha

by John F. Heerdink, Jr. July 15, 2026 245Views 0Likes

Spain’s shutout of France, Lionel Messi’s march with Argentina toward yet another World Cup final, and Lamine Yamal’s improbable baby‑photo link to the GOAT now intertwine into a single narrative that looks suspiciously like a long‑term growth chart for global football—and for…

From Abyss To Asteroid Belt: The New Resource Rush That Might Actually Deserve Your Risk Budget -( $TMC )

by John F. Heerdink, Jr. July 15, 2026 394Views 0Likes

Wall Street is quietly opening a new frontier: a modern-day resource rush that stretches from the abyssal plains of the Pacific to the rubble piles of the asteroid belt—and, for investors, the real story is that both are starting to look less…

Fusion’s Big Bet: Inside the $22 Billion “Artificial Sun” That Wants To Rewrite the Energy Playbook

by John F. Heerdink, Jr. July 15, 2026 365Views 0Likes

Wall Street has seen its share of big bets, but few are as audacious—or as delightfully bureaucratic—as ITER, the sprawling fusion experiment rising in the south of France. This public‑sector “artificial sun” carries a price tag north of €22 billion, a construction…

Humanoid Surgeons Scrub In: Is This the Day Intuitive Surgical Gets Nervous Or Check In? -( $ASXC $ISRG $MDT $NVDA )

by John F. Heerdink, Jr. July 14, 2026 1163Views 0Likes

Humanoid robots recently scrubbed in at UC San Diego and successfully removed gallbladders from live pigs, marking a world‑first teleoperated surgical milestone that investors in robotics, AI, and med‑tech will want on their radar. When Wall Street Meets the Operating Room For…

The AI Repricing of India: Investors Eye IT Services, Data Work, and Robotics -( $INFY $LTIM $TCS )

by John F. Heerdink, Jr. July 14, 2026 265Views 0Likes

The FT film argues that India’s tech model is being rewired by AI, with data annotation, robot training, and global capability centers replacing the old back-office script, while Indian IT services still carry major export weight and now face both risk and…

The Pivot Point: How Modular Medical (NASDAQ: MODD) Is Betting on the 70% of Diabetics That Big Insulin Forgot -( $MODD $PODD $MDT $TNDM )

by John F. Heerdink, Jr. July 14, 2026 197Views 0Likes

A San Diego upstart armed with FDA clearance, first commercial shipments, and an audacious two-part pump design is stepping into a multi-billion-dollar market that the industry's giants have repeatedly fumbled The Patient Nobody Wanted to Build For For decades, the diabetes device…

videos

Your Guide To Staying Informed In The Markets